Viron's product pipeline is sustained through the identification of novel candidates and therapies by an in-house discovery program. The discovery program utilizes a series of core competencies within the Company to screen candidate proteins for development as proprietary therapeutics. Viron currently has several lead candidates identified and has built a process that allows for the continual introduction of promising targets into the R&D process.